Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy |
| |
Authors: | Jeyarajah Elias J Cromwell William C Otvos James D |
| |
Affiliation: | LipoScience Inc., 2500 Sumner Boulevard, Raleigh, NC 27616, USA. |
| |
Abstract: | Laboratory measurements of plasma lipids (principally cholesterol and triglycerides) and lipoprotein lipids (principally low-density lipoprotein [LDL] and low-density lipoprotein [HDL] cholesterol) are the cornerstone of the clinical assessment and management of atherosclerotic cardiovascular disease (CVD) risk. LDL particles, and to a lesser extent very-low-density lipoprotein [VLDL] particles, cause atherosclerosis, whereas HDL particles prevent or reverse this process through reverse cholesterol transport. The overall risk for CVD depends on the balance between the "bad" LDL (and VLDL) and "good" HDL particles. Direct assessment of lipoprotein particle numbers us now possible through nuclear magnetic resonance spectroscopic analysis. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|